1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-19356
    Rocaglamide

    楝酰胺

    Inhibitor 99.34%
    Rocaglamide (Roc-A) 是从楝科植物中分离出来,可用于咳嗽,受伤,哮喘和炎症性皮肤病。Rocaglamide 是 T 细胞中一种有效的 NF-κB 活化抑制剂。Rocaglamide 是一种有效的选择性热休克因子 1 (HSF1) 活化抑制剂,IC50 约为 50 nM。Rocaglamide 还抑制翻译起始因子 eIF4A 的功能。Rocaglamide 还具有抗癌特性。
    Rocaglamide
  • HY-10529
    Betulinic acid

    白桦脂酸

    Modulator 98.43%
    Betulinic acid 是一种天然的五环三萜类化合物,为真核细胞拓扑异构酶 I (topoisomerase I) 的抑制剂,IC50 值为 5 μM,具有抗炎,抗疟疾,抗艾滋病和抗肿瘤等活性。
    Betulinic acid
  • HY-10496
    SC75741 Inhibitor 99.51%
    SC75741 是一种广泛,有效的 NF-κB 抑制剂,对 p65IC50 为 200 nM。SC75741 可阻断 influenza viruses 复制。SC75741 通过损害 NF-κB 亚基 p65 的 DNA 结合,导致细胞因子,趋化因子和促凋亡因子的表达降低,抑制 caspase 活化和阻断 caspase 介导的病毒核糖核蛋白 (viralribonucleoproteins) 的核输出。
    SC75741
  • HY-13812
    QNZ Inhibitor 99.51%
    QNZ (EVP4593) 强抑制 NF-κB 转录激活和 TNF-α 产生,IC50 分别为 11 和 7 nM。QNZ (EVP4593) 是一种保护神经的钙池操纵的钙通道 (SOC) 抑制剂。
    QNZ
  • HY-B2163
    Astaxanthin

    虾青素

    Inhibitor ≥98.0%
    Astaxanthin,红色膳食类胡萝卜素,是一种口服有效的强效抗氧化剂。Astaxanthin 可抑制 NF-κB,能在蛋白质水平下调高血糖中的 VEGF。Astaxanthin 通过激活 PPARγ 并减少 STAT3 和相关通路蛋白的表达,发挥抗癌细胞增殖、增加凋亡以及削弱迁移和侵袭的活性。Astaxanthin 还具有神经保护和抗炎活性可用于癌症,糖尿病视网膜病变,心血管疾病等研究以及动物饲料的着色。
    Astaxanthin
  • HY-N1914
    Ergothioneine

    麦角硫因

    Inhibitor 99.99%
    Ergothioneine 是一种具有口服活性的组氨酸甜菜碱的咪唑-2-硫酮衍生物。Ergothioneine 是 p38-MAPKAkt 的特异性抑制剂,在细胞免于应激诱导的凋亡中发挥保护作用。Ergothioneine 具有抗氧化活性。
    Ergothioneine
  • HY-N0191
    Andrographolide

    穿心莲内酯

    Inhibitor 99.89%
    Andrographolide 是一种 NF-κB 抑制剂,通过共价修饰内皮细胞中 p50 的半胱氨酸残基而抑制 NF-κB 活化,而不影响 IκBα 降解或 p50/p65 核易位。Andrographolide 具有抗病毒作用。
    Andrographolide
  • HY-P0151
    SN50 Inhibitor 99.98%
    SN50是可渗透细胞的 NF-κB 易位抑制剂。
    SN50
  • HY-B0190A
    Nafamostat mesylate

    甲磺酸萘莫司他

    99.85%
    Nafamostat mesylate (FUT-175),一种抗凝剂,是一种人工合成的丝氨酸蛋白酶 (serine protease) 抑制剂。 Nafamostat mesylate 具有抗癌和抗病毒作用,Nafamostat mesylate 通过上调肿瘤坏死因子受体 1 (TNFR1) 的表达诱导凋亡 (apoptosis),可用于动脉壁病理性增厚的发生发展3]
    Nafamostat mesylate
  • HY-N0452
    Hyperoside

    金丝桃甙

    Inhibitor 99.56%
    Hyperoside 是一种 NF-κB 抑制剂,从 Hypericum monogynum 中发现。Hyperoside 具有抗肿瘤、抗真菌、抗炎症、抗病毒和抗氧化的活性,并能诱导细胞凋亡。
    Hyperoside
  • HY-N0603
    20(S)-Ginsenoside Rg3

    20(S)-人参皂苷 Rg3

    Inhibitor 99.94%
    20(S)-Ginsenoside Rg3 是人参的主要成分。20(S)-Ginsenoside Rg3 抑制 Na+hKv1.4 通道,IC50 分别为 32.2±4.5 和 32.6±2.2 μM。20(S)-Ginsenoside Rg3 还抑制 NF-κB 活性和 COX-2 表达。
    20(S)-Ginsenoside Rg3
  • HY-B0185
    Lidocaine

    利多卡因

    Inhibitor 99.96%
    Lidocaine (Lignocaine) 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,可用于研究室性心律失常。
    Lidocaine
  • HY-N0045
    Ginsenoside Rg1

    人参皂苷 Rg1

    Inhibitor 99.91%
    Ginsenoside Rg1 是人参的主要活性成分之一。Ginsenoside Rg1 改善认知功能受损,通过降低大脑 水平来发挥作用。Ginsenoside Rg1 减少 NF-κB 核易位。
    Ginsenoside Rg1
  • HY-P3229
    SN52 Inhibitor 98.24%
    SN52 是一种有效的、竞争性的、细胞通透性的 NF-κB2 抑制剂。SN52 是 SN50 肽的变体,抑制 p52-RelB 异二聚体的核易位。SN52 对前列腺癌细胞有很强的放射增敏作用。SN52 可以用于癌症研究。
    SN52
  • HY-120501
    B022 Inhibitor 99.76%
    B022 是一种有效的选择性的 NF-κB 诱导激酶 (NIK) 抑制剂,Ki 为 4.2 nM,IC50 为 15.1 nM。B022 可保护肝脏免受毒素引起的炎症,氧化应激和伤害。
    B022
  • HY-N2065
    Withaferin A

    醉茄素A

    Inhibitor 99.92%
    Withaferin A 是从睡茄中分离到的甾体内酯,可以抑制 NF-kB 的活性,靶作用于波形蛋白 (vimentin),具有抗炎,抗肿瘤等功效。Withaferin A 是内皮蛋白 C 受体 (EPCR) 脱落的抑制剂。
    Withaferin A
  • HY-B1135
    Benzbromarone

    苯溴马隆

    99.80%
    Benzbromarone 是一种具有口服活性的抗痛风剂。Benzbromarone 具有抗炎、抗氧化应激和肾保护作用,可用于高尿酸血症和痛风的研究。
    Benzbromarone
  • HY-14645
    (-)-DHMEQ Inhibitor 98.72%
    (-)-DHMEQ (Dehydroxymethylepoxyquinomicin) 是一种有效,选择性且不可逆的 NF-κB 抑制剂,与半胱氨酸残基共价结合。(-)-DHMEQ 抑制 NF-κB 的核易位,并显示抗炎和抗癌活性。
    (-)-DHMEQ
  • HY-N0039
    Ginsenoside Rb1

    人参皂苷 Rb1

    Inhibitor 98.75%
    Ginsenoside Rb1 是中药人参的成分。Ginsenoside 抑制 Na+, K+-ATPase 活性,IC50 为 6.3±1.0 μM。Ginsenoside Rb1 也抑制 IRAK-1 激活及 NF-κB p65 的磷酸化。
    Ginsenoside Rb1
  • HY-N0510
    Aristolochic acid A

    马兜铃酸 A

    Inhibitor 99.98%
    Aristolochic acid A (Aristolochic acid I; TR 1736) 是植物提取物 Aristolochic acids 的主要成分,其存在于 AristolochiaAsarum 草本植物中。Aristolochic acid A 显着降低激活蛋白1 (AP-1) 和 NF-κB 活性。Aristolochic acid A 降低人细胞中膀胱癌相关 BLCAP 基因表达。
    Aristolochic acid A
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.